KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Capital Expenditures: 2010-2021

Historic Capital Expenditures for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2021 value amounting to $34,000.

  • TherapeuticsMD's Capital Expenditures fell 151.22% to -$21,000 in Q2 2022 from the same period last year, while for Jun 2022 it was -$8,000, marking a year-over-year decrease of 102.81%. This contributed to the annual value of $34,000 for FY2021, which is 83.57% down from last year.
  • According to the latest figures from FY2021, TherapeuticsMD's Capital Expenditures is $34,000, which was down 83.57% from $207,000 recorded in FY2020.
  • TherapeuticsMD's Capital Expenditures' 5-year high stood at $2.5 million during FY2019, with a 5-year trough of $34,000 in FY2021.
  • Over the past 3 years, TherapeuticsMD's median Capital Expenditures value was $207,000 (recorded in 2020), while the average stood at $897,000.
  • In the last 5 years, TherapeuticsMD's Capital Expenditures surged by 1,028.82% in 2019 and then slumped by 91.55% in 2020.
  • Over the past 5 years, TherapeuticsMD's Capital Expenditures (Yearly) stood at $61,817 in 2017, then soared by 251.10% to $217,040 in 2018, then spiked by 1,028.82% to $2.5 million in 2019, then slumped by 91.55% to $207,000 in 2020, then slumped by 83.57% to $34,000 in 2021.